Clinical Trial Update: Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease [Phase 3]

View source ↗

Summary

Phase 3 study of Telitacicept in active primary Sjögren's syndrome is currentlyRecruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Vor Biopharma | Conditions: Primary Sjogren's Disease | Phase 3 | Status: RECRUITING